可见光对培养的人RPE细胞生长的影响以及SOD和CAT的防护作用

目的：观察外源性超氧化物歧化酶(superoxide dismutase,SOD)和过氧化氢酶(caralase，CAT)对培养的人视网膜色素上皮(retinal pigment epithelium,RPE)细胞光化学损伤的保护作用． 方法:将铺满期原代培养的人RPE细胞分为三组．A组直接作光照处理，B组在培养液中加入SOD(90U/mL)和CAT(900U/ml)后30分钟进行光照，c组为对照组．光照强度2 400 Lx，时间6小时．处理结束后将三组细胞以2.4X10⁵/ml的密度分别接种于24孔板，每孔0.4m1l．于接种后1、3、5和7天观察细胞形志，井进行细胞计数． 结果：光照后3天时，A、B组细胞生长缓慢，C组细胞生长活跃，3天后B组细胞生长接近C组，比A组明显活跃(P＜0.05)相似文献   

干扰素治疗眼内新生血管病变

眼内新生血管病变是一类严重影响视力的疾病。日前，除全视网膜激光光凝外，尚缺乏简易有效的治疗方法．近来，α-干扰素应用于实验及临床治疗新生血管病变取得了良好的效果。由于α-干扰素可以抑制细胞胸腺嘧啶脱氧核苷的转运与磷酸化，进一步抑制细胞DNA的合成及其通过有丝分裂s期而抑制其增生．它可有效地抑制血管内皮细胞的生长与迁移，故可抑制新生血管的发生。目前，新生血管的发病机理及α-干扰素的药理学作用机理尚未能从分子生物学水平完全阐述清楚，但其效果肯定． （中华眼底病杂志，1994，10：121-123）     

视网膜分支静脉阻塞和新生血管形成

分析视网膜分支静脉阻塞240例245只眼(5人为双眼)，其中主干分支阻塞208只眼，黄斑分支阻塞37只眼。79只眼产生了新生血管，占总数的32.2%，占主干分支阻塞的37.9%．玻璃体出血39只眼，占分支阻塞的15.9%，占新生血管的49.4%。新生血管的危险因素是无灌注区形成、动脉灌注不良、阻塞处静脉严重受压．新生血管的发生随病程时间延长而增高，病程5年以上者高达83.3%。分支静脉阻塞盲目者20只眼占8.2%，其中因新生血管及并发症致盲者14只眼，占盲目的70%，占分支静脉阻塞的5.7%. （中华眼底病杂志，1994，10：67-70）     

硝酸甘油联合多巴酚丁胺、多巴胺治疗急性心肌梗死早期并急性左心衰竭

目的　探讨硝酸甘油与多巴酚丁胺、多巴胺合用治疗急性心肌梗死早期 (2 4h内 )并急性左心衰竭的效果及安全性。方法　 31例急性心肌梗死早期并急性左心衰竭患者 ,随机分为A ,B组 ,A组为硝酸甘油治疗组 ,在常规吸氧、镇静、止痛、溶栓、抗凝、解痉、利尿等治疗的基础上加用硝酸甘油 2 0～ 4 0 μg/min 静脉滴注 ;B组为联合治疗组 ,在A组治疗基础上 ,加用多巴酚丁胺 6～ 10 μg/ (kg·min) ,多巴胺 6～ 10μg/ (kg·min) ,用微量输液泵分开静脉滴注。结果　A组显效 4例 ,有效 7例 ,无效 4例 ,总有效率为 73% ;B组显效 11例 ,有效 3例 ,无效 2例 ,总有效率为 88%。两组总有效率比较差异有显著性 (P <0 0 1)。结论　在常规治疗基础上 ,硝酸甘油与多巴酚丁胺、多巴胺合用治疗急性心肌梗死早期并急性左心衰竭比单独加用硝酸甘油疗效更为显著 ,更加安全。     

大剂量甲基强的松龙冲击疗法治疗急性视神经炎临床疗效观察

目的：评估大剂量甲基强的松龙冲击疗法治疗急性视神经炎的疗效． 方法：应用大剂量甲基强的松龙冲击疗法治疗急性视神经炎30例．并与常量地塞米松疗法进行了病例对照观察。 结果：治疗组与对照组比较篷异有显著性(P<0.01)，治疗组见效快、副作用少、安全可靠。 结论：大剂量甲基强的松龙冲击疗法是治疗急性视神经炎的更为有效方法． （中华眼底病杂志，1996，12：186-187）     

Propofol and Sevoflurane in Subanesthetic Concentrations Act Preferentially on the Spinal Cord: Evidence from Multimodal Electrophysiological Assessment

Background: Animal experiments in recent years have shown that attenuation of motor responses by general anesthetics is mediated at least partly by spinal mechanisms. Less is known about the relative potency of anesthetic drugs in suppressing cortical and spinal electrophysiological responses in vivo in humans, particularly those, but not only those, connected with motor responses. Therefore, we studied the effects of sevoflurane and propofol in humans using multimodal electrophysiological assessment.

Methods: We studied nine healthy volunteers in two sessions during steady state sedation with 0.5, 1.0, and 1.5 [mu]g/l (targeted plasma concentration) propofol or 0.2 and 0.4 vol% (end-tidal) sevoflurane. Following a 15-min equilibration period, motor responses to transcranial magnetic stimulation and peripheral (H-reflex, F-wave) stimulation were recorded, while electroencephalography and auditory evoked responses were recorded in parallel.

Results: At concentrations corresponding to two thirds of C50 awake, motor responses to transcranial magnetic stimulation were reduced by approximately 50%, H-reflex amplitude was reduced by 22%, F-wave amplitude was reduced by 40%, and F-wave persistence was reduced by 25%. No significant differences between sevoflurane and propofol were found. At this concentration, the Bispectral Index was reduced by 7%, and the middle-latency auditory evoked responses were attenuated only mildly (Nb latency increased by 11%, amplitude PaNb did not change). In contrast, the postauricular reflex was suppressed by 77%.